XML 78 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2024
FINANCIAL INSTRUMENTS  
Schedule of financial assets and financial liabilities

Fair value

    

    

accounted

    

accounted

    

through

through other

Amortized

 profit or

comprehensive

As of December 31, 2024

cost

 loss

income

Total

Assets

  

  

  

Cash and cash equivalents

226,727

91,592

318,319

Investments

20,632

12,952

33,584

Trade receivables

296,424

296,424

Other receivables

16,378

3,496

19,874

Total

560,161

108,040

668,201

Liabilities

  

Trade payables

461,163

461,163

Borrowings

2,878,004

2,878,004

Leases liabilities

212,976

212,976

Other liabilities

16,280

1,244

17,524

Total

3,568,423

1,244

3,569,667

Fair value

    

    

accounted

    

accounted

    

through

through other

Amortized

profit or

comprehensive

As of December 31, 2023

cost

loss

income

Total

Assets

  

  

  

  

Cash and cash equivalents

275,506

72,424

347,930

Investments

26,371

243,588

269,959

Trade receivables

289,887

289,887

Other receivables

47,067

22

4,326

51,415

Total

638,831

316,034

4,326

959,191

Liabilities

Trade payables

779,088

779,088

Borrowings

4,634,160

4,634,160

Leases liabilities

193,036

193,036

Other liabilities

31,240

3,469

34,709

Total

5,637,524

3,469

5,640,993

Schedule of gains and losses of financial instruments by category

Gains and losses by category – Year 2024

    

Net gain/(loss)

    

Of which interest

Financial assets at amortized cost

(36,276)

39,991

Financial liabilities at amortized cost

1,632,087

(133,540)

Financial assets at fair value through profit or loss

(45,409)

Financial liabilities at amortized cost through profit or loss

(407)

Total

1,549,995

(93,549)

Gains and losses by category – Year 2023

    

Net gain/(loss)

    

Of which interest

Financial assets at amortized cost

137,618

54,055

Financial liabilities at amortized cost

(1,650,848)

(48,217)

Financial assets at fair value through profit or loss

193,309

140,072

Financial liabilities at amortized cost through profit or loss

(67,803)

Total

(1,387,724)

145,910

Gains and losses by category – Year 2022

    

Net gain/(loss)

    

Of which interest

Financial assets at amortized cost

 

39,509

 

30,957

Financial liabilities at amortized cost

 

139,282

 

(112,712)

Financial assets at fair value through profit or loss

 

(64,998)

 

(4,972)

Financial liabilities at fair value through profit or loss

 

(37,527)

 

Total

 

76,266

 

(86,727)

Schedule of financial assets and liabilities recognized at fair value and the level of hierarchy

As of December 31, 2024

    

Level 1

    

Level 2

    

Total

Assets

 

  

 

  

 

  

Current Assets

 

  

 

  

 

  

Mutual Funds (1) (2)

 

93,158

 

 

93,158

Government bonds (1) (2)

 

11,386

 

 

11,386

Other receivables: Compensation received for company acquisitions (3)

 

 

1,079

 

1,079

Non-current Assets

 

 

 

Other receivables: Compensation received for company acquisitions (3)

 

 

2,417

 

2,417

Total assets

 

104,544

 

3,496

 

108,040

Liabilities

 

  

 

  

 

  

Current Liabilities

 

  

 

  

 

  

Other liabilities: Debt for acquisition of NYSSA (3)

 

 

643

 

643

Non-current Liabilities

 

  

 

 

Other liabilities: Debt for acquisition of NYSSA (3)

 

 

601

 

601

Total liabilities

 

 

1,244

 

1,244

As of December 31, 2023

 

Level 1

 

Level 2

 

Total

Assets

 

  

 

  

 

  

Current Assets

 

  

 

  

 

  

Mutual Funds (1) (2)

 

31,414

 

 

31,414

Government bonds (1) (2)

 

284,598

 

 

284,598

Other receivables: DFI (4)

3,374

3,374

Other receivables: Indemnification assets (3)

22

22

Non-current Assets

 

 

 

Other receivables: DFI (4)

952

952

Total assets

316,012

4,348

320,360

Liabilities

 

 

 

Current Liabilities

 

 

 

Other liabilities: Debt for acquisition of NYSSA (3)

 

 

1,235

 

1,235

Non-current Liabilities

Other liabilities: Debt for acquisition of NYSSA (3)

2,234

2,234

Total liabilities

 

 

3,469

 

3,469

(1)

The Mutual funds are included in Cash and cash equivalentsand Investments. The Government bonds are included in Cash and cash equivalents and Investments.

(2)

The fair value is based on information obtained from active markets and corresponds to quoted market prices as of year-end. A market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.

(3)

The fair value was determined by the variation between the quoted values of certain public securities in foreign currency and Argentine pesos.

(4)

The fair value of financial instruments that are not negotiated in active markets is determined using valuation techniques. These valuation techniques maximize the use of market observable information, when available, and rely as little as possible on specific estimates of the Company. The techniques used for the measurement of financial instruments, are detailed below: a) DFI for forward purchases of US dollars and RMB, corresponds to the variation between the market prices at the end of the fiscal year and the time of agreement and; b) DFI interest rate swap corresponds to the present value of estimated future cash flows based on observable yield curves obtained in the market.

Schedule of fair value of financial debt

As of December 31, 2024, fair value of borrowings is as follows:

    

Carrying Value

    

Fair Value

Notes

 

2,410,891

 

2,246,719

Other borrowings

 

467,113

 

468,133

 

2,878,004

 

2,714,852

As of December 31, 2023, fair value of borrowings is as follows:

    

Carrying Value

    

Fair Value

Notes

 

2,843,432

 

2,635,181

Other borrowings

 

1,790,728

 

1,804,274

 

4,634,160

 

4,439,455

Schedule of position of DFIs in the consolidated statements of financial position and amounts recognized in Consolidated Income Statements and Consolidated Statements of Comprehensive Income

As of December 31,

2024

2023

Other receivables current - DFI: SOFR

    

    

3,374

Other receivables non current - DFI: SOFR

 

 

952

Total assets

 

 

4,326

Years ended December 31,

2024

2023

2022

Profit (loss)

Foreign currency exchange effect

    

2,995

    

17,273

    

(10,544)

Interests on borrowings

 

(2,747)

 

(2,705)

 

(997)

Financial results

 

248

 

14,568

 

(11,541)

DFI effects classified as hedges

 

(5,913)

 

2,859

 

4,122

Other comprehensive income (loss)

 

(5,913)

 

2,859

 

4,122

Schedule of offsetting of financial assets and financial liabilities in scope of IFRS 7

As of December 31, 2024

Trade

Other

Other

    

receivables

    

receivables

    

Trade payables

    

liabilities

Current and noncurrent assets (liabilities) - Gross value

 

312,860

 

23,427

 

(477,599)

 

(21,077)

Offsetting

 

(16,436)

 

(3,553)

 

16,436

 

3,553

Current and noncurrent assets (liabilities) – Carrying Value

 

296,424

 

19,874

 

(461,163)

 

(17,524)

As of December 31, 2023

Trade

Other

Other

    

receivables

    

receivables

    

Trade payables

    

liabilities

Current and noncurrent assets (liabilities) - Gross value

 

305,745

 

53,314

 

(794,946)

 

(36,608)

Offsetting

 

(15,858)

 

(1,899)

 

15,858

 

1,899

Current and noncurrent assets (liabilities) – Carrying Value

 

289,887

 

51,415

 

(779,088)

 

(34,709)